Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123408 · ClinicalTrials.gov registry record · NA
Clozapine and Olanzapine Treatment of Aggression
A NA study, sponsored by Nathan Kline Institute for Psychiatric Research.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01123408 is a NA study that has completed, run by Nathan Kline Institute for Psychiatric Research. The registered enrollment target is 110 participants.
The verdict
NCT01123408, a NA study, has completed, sponsored by Nathan Kline Institute for Psychiatric Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
This was a double-blind randomized study with three treatment arms: clozapine, olanzapine and haloperidol. We compared these three medications in the treatment of aggressive behavior over a 12 week period.
Interventions
- DRUG Haloperidol
- DRUG Olanzapine
- DRUG Clozapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 1999-06 |
| Est. Completion | 2004-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123408
The ClinicalTrials.gov registry entry for NCT01123408 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nathan Kline Institute for Psychiatric Research, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Haloperidol is the first listed.
NCT01123408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01123408 about?
NCT01123408 is a clinical study titled "Clozapine and Olanzapine Treatment of Aggression". This was a double-blind randomized study with three treatment arms: clozapine, olanzapine and haloperidol. We compared these three medications in the treatment of aggressive behavior over a 12 week period.
What is the current status of trial NCT01123408?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 1999-06. Estimated completion is 2004-07.
What interventions are being tested in trial NCT01123408?
The interventions under investigation include: Haloperidol (DRUG), Olanzapine (DRUG), Clozapine (DRUG).
Who is sponsoring clinical trial NCT01123408?
This trial is sponsored by Nathan Kline Institute for Psychiatric Research, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.